SaMD Development Support

We apply the applicable EU and US software-qualification tests to intended use, and we engineer the product as medical device software from the design phase whenever SaMD is a reasonable possibility — so later qualification does not force a rebuild of architecture, logs or documentation.

When this is needed

  • Intended use may place software in a medical device / SaMD category
  • Engineering and RA need a shared plan before claims harden
  • The product should be built to regulated-software expectations even if qualification is not yet filed
  • Teams need a clear line between wellness / research tooling and medical device software
  • AI-enabled clinical decision support raises both device and AI-governance questions

How we work

  1. Intended use — claims, users, clinical vs non-clinical language
  2. Qualification view — apply MDCG / FDA / IMDRF software tests to that intended use and state how likely medical-device / SaMD qualification is
  3. Design as regulated software — lifecycle, risk, logging and evidence from the start when qualification is a reasonable possibility
  4. Product and documentation plan — engineering collaboration suited to IEC 62304-oriented work
  5. Coordination — device readiness and regulatory writing as needed; the client remains manufacturer and filing party

See How we work and Medical software for engineering standards (IEC 62304, ISO 14971, ISO 13485-aligned practices).

Qualification

Whether software is medical device software or SaMD is a test against intended use and published frameworks (IMDRF SaMD, MDCG software guidance in the EU, FDA device-software / SaMD guidance in the US). Those tests usually make the likely qualification clear well before any FDA marketing authorization or notified-body certificate. We apply them to the product and give a reasoned view.

  • Medical purpose vs wellness, administrative or research-only language
  • Users, clinical context and potential harm if the software fails
  • Marketing claims vs what the software actually does
  • What remains genuinely open vs what the rules already decide

A qualification view is not an FDA, notified-body or competent-authority decision. The client remains the manufacturer, submission holder and party of record for any filing.

Design-phase discipline

Where there is a reasonable chance the product will be SaMD or medical device software, we design and write it that way from the outset: software safety class, risk controls, change history, logs and documentation that a later technical file or DHF can use. That reduces the cost of redesign, retrospective logging and documentation catch-up if qualification is confirmed.

Lifecycle and documentation themes

  • Software development planning, safety classification and requirements suitable for later technical-file / DHF inputs
  • Risk management inputs (ISO 14971-oriented) tied to software failure modes
  • SOUP / third-party component awareness and change control expectations
  • Verification and validation evidence planning appropriate to risk class
  • Cybersecurity and data-protection design themes proportional to product risk

In scope

  • Reasoned SaMD / medical-device-software qualification against applicable frameworks
  • Engineering and documentation from design onward when qualification is a reasonable possibility
  • Coordination with regulatory documentation and device readiness workstreams

Example deliverables

  • Intended-use and qualification notes with a reasoned SaMD / device-software view
  • Planning artefacts for engineering and documentation tracks
  • Lifecycle, logging and evidence inputs the client can take into QMS and filings
  • Traceability and technical-file inputs when scoped with medical-software engineering

Out of scope

  • Granting FDA marketing authorization, CE marking or any certificate
  • Acting as a notified body, competent authority or the FDA

FAQ

Will you tell us if our app is SaMD?
Yes. We apply the applicable qualification tests to intended use and give a reasoned view of whether the software is likely medical device / SaMD software. That view is not a substitute for an FDA, notified-body or competent-authority decision. The client remains the manufacturer and filing party.

Why design as SaMD before a formal filing?
If qualification is a reasonable possibility, building to those lifecycle, log and documentation expectations from the design phase is cheaper than re-engineering after claims harden.

Is this the same as medical software engineering?
Closely related. SaMD support is the qualification view plus design-phase discipline when device rules may apply; medical software is the broader engineering and documentation depth.

Medical software · Regulatory support · Device readiness · Digital health

For role boundaries (regulator, notified body, certification, outcomes), see Trust.

Ready to discuss a programme?

Tell us about your organisation and the type of support you need.